| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 3 |
| 1 | DOXORUBICIN | 3 |
| 2 | METHOTREXATE | 3 |
| 3 | METHOTREXATE SODIUM | 3 |
| 4 | IFOSFAMIDE | 2 |
| 5 | ADALIMUMAB | 1 |
| 6 | ASPARAGINASE | 1 |
| 7 | ASPIRIN | 1 |
| 8 | ASPIRIN 325 MG | 1 |
| 9 | ASPIRIN 81 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0025 |
| 1 | ASPARAGINASE | 1 | 0.0003 |
| 2 | IFOSFAMIDE | 2 | 0.0002 |
| 3 | MERCAPTOPURINE | 1 | 0.0001 |
| 4 | DOXORUBICIN | 3 | 0.0001 |
| 5 | CISPLATIN | 3 | 0.0001 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
| 7 | CYTARABINE | 1 | 0.0000 |
| 8 | VEDOLIZUMAB | 1 | 0.0000 |
| 9 | TRASTUZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 4 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Interferon beta [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |